Literature DB >> 26937265

Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics.

Nicholas J Farber1, Yan Wu2, Lily Zou3, Puneet Belani3, Eric A Singer4.   

Abstract

Entities:  

Keywords:  Renal cell carcinoma imaging; diffusion MRI; kidney cancer surveillance; molecular imaging; perfusion MRI; radiation exposure

Year:  2015        PMID： 26937265      PMCID： PMC4770557     

Source DB:  PubMed          Journal:  Kidney Cancer J        ISSN： 1933-0863


× No keyword cloud information.
  43 in total

1.  Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT?

Authors:  Ingrid Millet; Fernanda Curros Doyon; Denis Hoa; Rodolphe Thuret; Samuel Merigeaud; Isabelle Serre; Patrice Taourel
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

Review 2.  Risk factors for NSF: a literature review.

Authors:  Martin R Prince; Hong Lei Zhang; Giles H Roditi; Tim Leiner; Walter Kucharczyk
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

3.  Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.

Authors:  John S Lam; Oleg Shvarts; John T Leppert; Allan J Pantuck; Robert A Figlin; Arie S Belldegrun
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

Review 4.  Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

Authors:  Maxine Sun; Shahrokh F Shariat; Christopher Cheng; Vincenzo Ficarra; Masaru Murai; Stéphane Oudard; Allan J Pantuck; Richard Zigeuner; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2011-06-30       Impact factor: 20.096

5.  Patterns of surveillance imaging after nephrectomy in the Medicare population.

Authors:  Michael A Feuerstein; Coral L Atoria; Laura C Pinheiro; William C Huang; Paul Russo; Elena B Elkin
Journal:  BJU Int       Date:  2015-06-22       Impact factor: 5.588

Review 6.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

7.  Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.

Authors:  Rotem S Lanzman; Phil M Robson; Maryellen R Sun; Amish D Patel; Kimiknu Mentore; Andrew A Wagner; Elizabeth M Genega; Neil M Rofsky; David C Alsop; Ivan Pedrosa
Journal:  Radiology       Date:  2012-10-09       Impact factor: 11.105

8.  Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.

Authors:  Payal Kapur; Samuel Peña-Llopis; Alana Christie; Leah Zhrebker; Andrea Pavía-Jiménez; W Kimryn Rathmell; Xian-Jin Xie; James Brugarolas
Journal:  Lancet Oncol       Date:  2013-01-16       Impact factor: 41.316

Review 9.  Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols?

Authors:  Yu-Kuan Lin; Lori Gettle; Jay D Raman
Journal:  BJU Int       Date:  2013-01-18       Impact factor: 5.588

10.  Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.

Authors:  Chaitanya R Divgi; Robert G Uzzo; Constantine Gatsonis; Roman Bartz; Silke Treutner; Jian Qin Yu; David Chen; Jorge A Carrasquillo; Steven Larson; Paul Bevan; Paul Russo
Journal:  J Clin Oncol       Date:  2012-12-03       Impact factor: 44.544
View more
  8 in total

1.  Renal cell carcinoma: the search for a reliable biomarker.

Authors:  Nicholas J Farber; Christopher J Kim; Parth K Modi; Jane D Hon; Evita T Sadimin; Eric A Singer
Journal:  Transl Cancer Res       Date:  2017-06       Impact factor: 1.241

Review 2.  Imaging Protocols for Active Surveillance in Renal Cell Carcinoma.

Authors:  Christine W Liaw; Jared S Winoker; Reza Mehrazin
Journal:  Curr Urol Rep       Date:  2018-08-13       Impact factor: 3.092

3.  Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma.

Authors:  Parth K Modi; Nicholas J Farber; Eric A Singer
Journal:  Transl Cancer Res       Date:  2016-06       Impact factor: 1.241

4.  The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Authors:  Hiten D Patel; Maneka Puligandla; Brian M Shuch; Bradley C Leibovich; Anil Kapoor; Viraj A Master; Charles G Drake; Daniel Yc Heng; Primo N Lara; Toni K Choueiri; Deborah Maskens; Eric A Singer; Scott E Eggener; Robert S Svatek; Walter M Stadler; Suzanne Cole; Sabina Signoretti; Rajan T Gupta; Marc Dror Michaelson; David F McDermott; David Cella; Lynne I Wagner; Naomi B Haas; Michael A Carducci; Lauren C Harshman; Mohamad E Allaf
Journal:  Future Oncol       Date:  2019-04-10       Impact factor: 3.404

5.  Emergence of Radiomics: Novel Methodology Identifying Imaging Biomarkers of Disease in Diagnosis, Response, and Progression.

Authors:  Edward Florez; Ali Fatemi; Pier Paolo Claudio; Candace M Howard
Journal:  SM J Clin Med Imaging       Date:  2018-03-15

6.  Initial Evaluation of Computer-Assisted Radiologic Assessment for Renal Mass Edge Detection as an Indication of Tumor Roughness to Predict Renal Cancer Subtypes.

Authors:  Rahul Rajendran; Kevan Iffrig; Deepak K Pruthi; Allison Wheeler; Brian Neuman; Dharam Kaushik; Ahmed M Mansour; Karen Panetta; Sos Agaian; Michael A Liss
Journal:  Adv Urol       Date:  2019-04-23

7.  Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Through CT-Based Tumoral and Peritumoral Radiomics.

Authors:  Yanqing Ma; Zheng Guan; Hong Liang; Hanbo Cao
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

Review 8.  Potential Applications of Nanotechnology in Urological Cancer.

Authors:  Ming-Hui He; Li Chen; Ting Zheng; Yu Tu; Qian He; Hua-Lin Fu; Ju-Chun Lin; Wei Zhang; Gang Shu; Lili He; Zhi-Xiang Yuan
Journal:  Front Pharmacol       Date:  2018-07-09       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.